$SUJA

Box Michael purchased $16K of SUJA

Box Michael (Chief Operations Officer) purchased 2,500 shares of SUJA LIFE, INC. (SUJA) at $6.43 on 2026-08-10.

Original reporting
SEC EDGAR · Box Michael
Published Aug 12, 2026, 8:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 8:15 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SUJA
Bullish
low confidence
Mentioned
$SUJA
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SUJABullishLow
01

Why it matters

The newest disclosed fact is the COO’s open-market purchase details (shares, price, total value) and post-transaction holdings.

02

Market read

Traders may note the insider buy as a minor sentiment input, but there is no fundamental update or guidance change in the text.

03

What to watch

No 10b5-1 plan is cited, but the filing does not explain motivation, and the purchase size is modest relative to typical market-moving thresholds.

Relevance 4/10Novelty 3/10Timing: Form 4 filed 2026-08-12, covering a purchase dated 2026-08-10.

Background

The article is an SEC Form 4 insider transaction disclosure for SUJA Life, Inc.

Company-level read

Ticker impact

$SUJABullishLow confidence
Context

SUJA Life COO Box Michael bought 2,500 shares on 2026-08-10 at $6.4278, totaling $16,069.50, per Form 4 filed 2026-08-12.

Expected impact

Limited near-term impact; any effect is likely sentiment-driven and short-lived.

Evidence & confidence

The transaction is an insider buy, but the dollar value is small and there is no 10b5-1 plan or other accompanying corporate catalyst disclosed.

Market effects

No sector-level signal; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine or discretionary and may not reflect a material change in outlook, especially at small sizes.

Key entities

  • SUJA Life, Inc.

    Company whose insider transaction is disclosed via SEC Form 4.

  • Box Michael

    Chief Operations Officer who purchased shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SUJAMed

Suja Defies Grocery Slowdown With Double-Digit Sales Growth in Q2

Suja Life, Inc. (Nasdaq: SUJA) reported Q2 net sales up 11.6% year over year to $83.9 million, citing volume growth and improved distribution. Gross profit increased 9.9% to $39.2 million, or 46.7% of sales. The company raised its 2026 outlook to $360 to $369 million net sales from $326.6 million in 2025.

$SUJAMed

SUJA LIFE, INC. (SUJA): Results of Operations and Financial Condition

SUJA LIFE, INC. (SUJA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 sujalifeq22026earningsrele.htm EX-99.1 Document Suja Life Reports Second Quarter 2026 Financial Results Net sales increased 11.6% year-over-year to $83.9 million Updates fiscal year 2026 outlook OCEANSIDE, CA, August 4, 2026 – Suja Life, Inc. (NASDAQ: SUJA) (“Suja Life,

$SUJAMedAI 9/10

Suja Life Reports First Quarter 2026 Financial Results

Suja Life (NASDAQ: SUJA) reported first-quarter 2026 net sales of $107.1 million, up 22.5% year over year from $87.4 million. Adjusted EBITDA rose 66.3% to $25.0 million, with margin expanding to 23.4%. Net income was $7.7 million versus a prior-year net loss. The company initiated 2026 guidance: net sales $367–$371 million and Adjusted EBITDA $70–$72 million.

$SUJAMed

Suja Life (NASDAQ:SUJA) Upgraded to “Strong-Buy” at Evercore

Evercore upgraded Suja Life (NASDAQ:SUJA) to a “strong-buy” rating in a Monday research note, according to Zacks.com. Other firms also initiated coverage: Goldman Sachs set a $31 target and a “buy,” Jefferies set a $25 target and a “buy,” and William Blair rated “outperform.” MarketBeat data show a consensus “Buy” and average target $26.67.

$NVDAMed

Here are Monday's biggest analyst calls: Nvidia, Apple, Tesla, Broadcom, Microsoft, IBM, Meta, Tyson Foods & more

Wall Street analysts issued multiple calls Monday. Goldman initiated HawkEye 360 as buy; Morgan Stanley upgraded Dell to equal weight; Wells Fargo upgraded Tandem Diabetes Care to overweight. Citizens initiated Microsoft at Market Outperform with a $550 target; Barclays initiated IBM at overweight with a $350 target. Cantor reiterated Tesla overweight; RBC reiterated Meta outperform. Broadcom was reiterated overweight by Morgan Stanley, raising its target to $485.